| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | -0.38 | 0.2 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.07 | 0.2 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.2 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.073 | 0.2 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.2 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.2 |